Dr. Ramnath Shenoy K
Consultant - Medical & Haemato-Oncology
Dr. Ramnath Shenoy is an experienced Medical and Haemato-Oncologist with expertise in managing blood cancers, breast, lung, gastrointestinal, gynecological, urological, liver, bone, and pediatric solid tumors. He is skilled in delivering chemotherapy, immunotherapy, targeted and hormonal therapies, along with advanced molecular diagnostics.
He has presented at leading global conferences including ESMO, ASH, and SIOG, receiving international recognition such as the ASH Abstract Achievement Award.
With multiple research publications in reputed journals and prior academic roles at Tata Memorial Hospital, Mumbai, and Kasturba Medical College, Manipal, Dr. Shenoy combines clinical excellence with compassionate patient care.
- Management of all types of cancers such as blood cancers (leukemia, lymphoma and myeloma), breast, lung, gastrointestinal, gynecological, head and neck, urological, liver, bone cancers and pediatric solid malignancies
Delivery of chemotherapy, immunotherapy, targeted therapy & hormonal therapy
Molecular diagnostics and therapeutics
- Clinical profile and outcome of HER2-positive breast cancer patients with brain metastases treated with HER2-targeted therapy: Real-world experience; ESMO 2019 conference, Barcelona, Spain.
- Efficacy of artesunate for treatment of cytomegalovirus reactivations in allogeneic hematopoietic stem cell transplant recipients who are intolerant/unsuitable for ganciclovir therapy; American Society of Haematology (ASH) conference 2019, Florida, USA — received ASH Abstract Achievement Award.
- Early data on the differential value of the Onco-MPI index in older Indian patients with cancer; SIOG virtual international conference, Geneva, Switzerland, November 2021.
PUBLICATIONS:
- Shenoy R et al. Validation of the Onco-MPI in predicting short-term mortality in older Indian patients with cancer. Journal of Geriatric Oncology, ISSN: 1879-4068, Vol: 14, Issue: 6
- Shenoy, R., Panda, G., Bonda, V.N.A. et al. Feasibility of Delivering High-Dose Methotrexate in Adolescent and Adult All Patients: A Retrospective Study. Indian J Hematol Blood Transfus 38, 638–642 (2022)
- Gokarn, A., Shenoy, R., Punatar, S. et al. Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplant 58, 209–211 (2023)
- Bhargava P, Rathnasamy N, Shenoy R, et al. Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World Experience. JCO Glob Oncol. 2022
- Mailankody, S., Sherigar, P., Pai, A, Shenoy R et al. PENS approach for breaking bad news in the oncology outpatient setting: a real-world report. Support Care Cancer 31, 13 (2023)
- Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomized, phase 3 trial Lancet Global Health- Volume 8, issue 9, e1213-e1222, September 01, 2020
- ‘’Targeting NTRK fusions in Cancers” a chapter in evidence-based Management of cancers in India -2021
- Shenoy R, Moideen F, Lashkari HP. A child with bulky kidneys and renal failure. Indian J Med Paediatr Oncol 2018;39:388-90
Other Similar Doctors
Aster MIMS Kasaragod
